Apple Watch Series 11 Gets FDA Nod for Groundbreaking Hypertension Alerts

Breaking News: Apple Watch Series 11 Receives FDA Approval for Hypertension Alerts The US Food and Drug Administration (FDA) has granted approval to the Apple Watch Series 11's hypertension alert feature, allowing users in 150 countries to receive notifications when their blood pressure may be a concern. This new functionality will be available starting September 19, coinciding with the release of the Watch 11 and Ultra Watch 3. Timeline: September 19: Apple Watch Series 11 and Ultra Watch 3 ship with hypertension alert feature FDA approval granted to Apple's new health feature Immediate Impact: The hypertension alert feature uses a machine learning algorithm that analyzes data from the Watch's optical heart sensor over a month-long period. This allows users to receive notifications when their blood pressure may be high, potentially preventing serious complications. Background Context: Hypertension affects over 1 billion people worldwide and can lead to cardiovascular disease if left untreated. Apple's new feature is designed to detect patterns associated with hypertension in the background, without requiring users to manually measure their blood pressure. What Happens Next: As the Apple Watch Series 11 and Ultra Watch 3 become available on September 19, users will be able to take advantage of this innovative health feature. With FDA approval in place, Apple is poised to expand its presence in the healthcare industry, building on last year's success with its over-the-counter Hearing Aid function. *This story is developing. Information compiled from Engadget reporting.*